Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.62 |
| ▸ | NTMT1 | Q9BV86 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
| ▸ | LSS | P48449 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3839959 | 1.00 | CHRNA7 (0.62) | CHRNA7NTMT1KDM4ENPC1MAPT | |
| SCHEMBL1459274 | 0.88 | CHRNA7 (0.65) | CHRNA7NTMT1MAPTCHRNB2CHRNA4 | |
| SCHEMBL1459276 | 0.88 | CHRNA7 (0.65) | CHRNA7NTMT1MAPTCHRNB2CHRNA4 | |
| SCHEMBL3840226 | 0.86 | CHRNA7 (0.61) | CHRNA7CHRNB2CHRNA4HTR3A | |
| SCHEMBL3840224 | 0.86 | CHRNA7 (0.61) | CHRNA7CHRNB2CHRNA4HTR3A | |
| SCHEMBL1542809 | 0.85 | CHRNA7 (0.65) | CHRNA7NTMT1CHRNB2CHRNA4LSS | |
| SCHEMBL3840206 | 0.85 | CHRNA7 (0.65) | CHRNA7NTMT1NPC1RAB9ACHRNB2 | |
| SCHEMBL1542514 | 0.85 | CHRNA7 (0.65) | CHRNA7NTMT1CHRNB2CHRNA4 | |
| SCHEMBL3840208 | 0.85 | CHRNA7 (0.65) | CHRNA7NTMT1NPC1RAB9ACHRNB2 | |
| SCHEMBL5421431 | 0.85 | CHRNA7 (0.65) | CHRNA7CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8236803-B2 | Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists | NOVARTIS AG (CH) | 2012-08-07 | — | — | US | claimed |
| EP-1537104-B1 | AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS | NOVARTIS AG (CH) | 2009-11-11 | — | — | EP | claimed |
| EP-1537104-B1 | AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS | NOVARTIS AG (CH) | 2009-11-11 | — | — | EP | disclosed |